MEG3 and gastric cancer: Interestingly, we found that the lower MEG3 was associated with pM stage (Fig. 1c, p < 0.01, metastasis vs. non metastasis) and pTNM stage (Fig. 1d, p < 0.01, stageIvs. IV; p < 0.01, stage II vs. IV; p < 0.01, stage III vs. IV) in GC patients.